Search by Drug Name or NDC

    NDC 50090-5180-00 Lansoprazole 30 mg/1 Details

    Lansoprazole 30 mg/1

    Lansoprazole is a ORAL CAPSULE, DELAYED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by A-S Medication Solutions. The primary component is LANSOPRAZOLE.

    Product Information

    NDC 50090-5180
    Product ID 50090-5180_ee55f98b-3781-4ac3-ad33-4e265b551603
    Associated GPIs
    GCN Sequence Number 030107
    GCN Sequence Number Description lansoprazole CAPSULE DR 30 MG ORAL
    HIC3 D4J
    HIC3 Description PROTON-PUMP INHIBITORS
    GCN 01698
    HICL Sequence Number 008993
    HICL Sequence Number Description LANSOPRAZOLE
    Brand/Generic Generic
    Proprietary Name Lansoprazole
    Proprietary Name Suffix n/a
    Non-Proprietary Name Lansoprazole
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE, DELAYED RELEASE
    Route ORAL
    Active Ingredient Strength 30
    Active Ingredient Units mg/1
    Substance Name LANSOPRAZOLE
    Labeler Name A-S Medication Solutions
    Pharmaceutical Class Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA207394
    Listing Certified Through 2024-12-31

    Package

    NDC 50090-5180-00 (50090518000)

    NDC Package Code 50090-5180-0
    Billing NDC 50090518000
    Package 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (50090-5180-0)
    Marketing Start Date 2020-09-28
    NDC Exclude Flag N
    Pricing Information N/A